Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

PannTheraPi Announces Significant Clinical Development and Strategic Milestones

Summary by WBOC 16
Regulatory submission filed to initiate a Phase 2a trial of its drug candidate, PTI5803 in patients with focal

1 Articles

WBOC 16WBOC 16
Center

PannTheraPi Announces Significant Clinical Development and Strategic Milestones

Regulatory submission filed to initiate a Phase 2a trial of its drug candidate, PTI5803 in patients with focal

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

WBOC 16 broke the news in on Tuesday, April 14, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Salisbury, Maryland icon

Salisbury, Maryland

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal